Abstract
There are many reports concerning the toxicity of oxygen in various disease states1–4 Recently, attention has been called to the unfavorable effects of active oxygen in renal diseases5–9. We have reported that the hydroxyl radical plays an important role in vitro10 and in isolated rat hepatocytes11 in the peroxidation of creatinine (CRN) to methylguanidine (MG), a guanidino compound known to be a potent uremic toxin. In this study, we investigate the correlation between some markers of the peroxidative state and the concentration of various guanidino compounds in the sera of patients undergoing regular hemodialysis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Misra, H.P., Fridovich, I,, Superoxide dismutase and the oxygen enhancement of radiation lethality, Arch. Biochenu Biophys. 176 (1976) 577–581.
Totter, J.R, Spontaneous cancer and its possible relationship to oxygen metabolism, Proc. Natl, Acad. Sci, USA 77 (1980) 1763–1767,
Weitzman, S.A., Stossel, T.P., Effects of oxygen raidcal scavengers and antioxidants on phagocyte-induced mutagenesis, J, Immun. 128 (1982) 2770–2772.
Freeman, B.A., Crapo, J.D., Free radical and tissue injury, Lab. Invest. 47 (1982) 412–426.
Fillet, H., Elion, E., Sullivan, J., Sherman, R., Zabriskie, J,B., Thiobarbituric acid reactive material in uremic blood, Nephron 29 (1981) 40–43.
Giardini, O., Taccone-Gallucci, M., Lubrano, R., Ricciardi-Tenore, G., Bandino, D., Silvi, I., Ruberto, U., Casciani, C.U., Evidence of red blood cell membrane lipid peroxidation in haemodialysis patients, Nephron 36 (1984) 235–237.
Kuroda, M., Asaka, S., Tofuku, Y., Takeda, R., Serum antioxidant activity in uremic patients, Nephron 41 (1985) 293–298.
Rehan, A., Johnson, K., Wiggins, R.C., Kunkel, R.G., Ward, P.A., Evidence for the role of oxygen radical in acute nephrotoxic nephritis, Lab. Invest. 51 (1984) 396–403.
Paller, M.S., Hoidal, J.R., Ferris, T.F., Oxygen free radical in ischemic acute renal failure in the rat, J. Clin. Invest. 74 (1984) 1156–1164.
Nagase, S., Aoyagi, K., Narita, M., Tojo, S., Active oxygen in methylguanidine synthesis, Nephron 44 (1986) 299–303.
Aoyagi, K., Nagase, S., Narita, M., Tojo, S., Role of active oxgen on methylguanidine synthesis in isolated rat hepatocytes, Kidney Int. 32 (1987) S229–S233.
Nagase, S., Aoyagi, K., Narita, M., Tojo, S., Biosynthesis of methyl-guanidine in isolated rat hepatocytes and in vivo, Nephron 40 (1985) 470–475.
Ramsay, W.N.M., The determination of iron in blood plasma or serum, Biochem. J. 53 (1953) 227–231.
Yagi, K., A simple fluorometric assay for lipoperoxide in blood plasma, Biochem. Med. 15 (1976) 212–216.
Baker, L.R.I, Marshall, R.D., A reinvestigation of methylguanidine concentration in sera from normal and uraemic subjects, Clin, Sci. 41 (1971) 563–568.
Giovannetti, S., Balestri, P.L., Barsotti, G., Methylguanidine in uremia, Arch. Intern. Med. 131 (1973) 709–713.
Kopple, J.D., Gordon, S.I., Wang, M., Swendseid, M.E., Factors affecting serum and urinary guanidinosuccinic acid levels in normal and uremic subjects, J. Lab. Clin. Med. 90 (1977) 303–311.
Halliwell, B., Gutterridge, M.C., Oxygen toxicity, oxygen radicals, transition metals and disease, Biochem. J. 219 (1984) 1–14.
Balinski, T., Krawiec, Z., Liczmanski, A., Litwinska, J., Is hydroxyl radical generated by Fenton reaction in vivo? Biochem. Biophys, Res. Commun. 130 (1985) 533–539.
Nakano, H., Sugioka, K., Nakano, M., Mizukami, M., Kimura, H., Tero-Kubota, S., Ikegami, Y., Importance of Fe2+-ADP and the relative unimportance of -OH in the mechanism of mitomycin C-induced Lipid peroxidation, Biochem. Biophys. Acta 796 (1984) 285–293.
Lipschitz, D.A., Cook, J.D., Finch, C. A., A clinical evaluation of serum ferritin as an index of iron stores, New Engl. J. Med. 290 (1974) 1213–1216.
Yagi, K., Assay for serum lipid peroxidase level and its clinical sig-nificance, in: “Lipid peroxides in biology and medicine”, K. Yagi Ed., Academic Press, New York (1982) pp. 223–242.
Bucher, J.R., Tien, M., Aust, S.D., The requirement for ferric in the initiation of lipid peroxidation by chelated ferrous iron, Biochem. Biophys. Res. Commun. 111 (1983) 777–784.
Bacon, B.R., Tavill, A.S., Brittenham, G.M., Park. C.H., Recknagel, R.O., Hepatic lipid peroxidation in vivo in rats with chronic iron overload, J. Clin. Invest. 71 (1983) 429–439.
Willmore, L.J., Rubin, J.J., Formation of malonaldehyde and focal brain edema induced by subpial injection of FeC12 into rat isocortex, Brain Res. 246 (1982) 113–119.
Hatakeyama, Y., Chiba, E., Arai, S., Suzuki, T., Removal rate of guanidino compounds in various method of hemodialysis, Proc. Annual Meeting Jpn. Guanidino Compounds Res. Assoc. 5 (1982) 39–42 (in Japanese).
Major, R.H., Weber, C.J., The possible increase of guanidine in the blood of certain persons with hypertension. Arch. Int. Med. 40 (1927) 891–899.
De Wesselow, O.L.V.S., Griffiths, W.G., The blood guanidine in hypertension, Brit. J. Exper. Path. 13 (1932) 428–434.
Andes, J., Lineger, C.R. and Myers, V.C., Guanidine-like substances in the blood. II. Blood guanidine in nitrogen retention and hypertension, J. Lab. Clin. Med. 22 (1937) 1209–1216.
Carr, M.H., Schloerb, P.R., Analysis for guanidine and methylguanidine in uremic plasma, Anal. Biochem. 1 (1960) 221–227.
Menichini, G.C., Giovannetti, S., Lupetti, S., A new method for measuring guanidine in uremia, Experientia 29 (1972) 506–507.
Murray, M., Hoffman, C.R., The occurrence of guanidine-like substances in the blood in essential epilepsy, J. Lab. Clin. Med. 25 (1940) 1072–1073.
Greenblatt, I.J., Guanidinuria, J. Biol. Chem. 136 (1941) 791.
Hollunger, G., Guanidines and oxidative phosphorylations, Acta Pharmacol. Toxicol. 11 (1955) S1–S84.
Rajagopalan, K.V., Fridovich, I., Handler, P., Inhibition of enzyme activity by urea, Fed. Proc. 19 (1960) 49.
Kihara, H., Prescott, J.M., Snell, E.E., The bacterial cleavage of canavanine to homoserine and guanidine, J. Biol. Chem. 217 (1955) 497–503.
Walker, J.B., Walker, M.S., The enzymatic reduction of hydroxyguanidine, J. Biol. Chem. 234 (1959) 1481–1484.
Takahara, K., Nakanishi, S., Natelson, S., Study on the reductive cleavage of canavanine and canavaninosuccinic aicd, Arch. Biochem. Biophys. 145 (1971) 85–95.
Reiter, A.J., Horner, W.H., Studies on the metabolism of guanidine compounds in mammals. Formation of guanidine and hydroxyguanidine in the rat,. Arch. Biochem. Biophys. 197 (1979) 126–131.
Mikami, H., Orita, Y., Ando, A., Fujii, M., Kikuchi, T., Yoshihara, K., Okada, A., Abe, H., Metabolic pathway of guanidino compounds in chronic renal failure, in: “Urea cycle diseases”, A. Lowenthal, A. Mori, B. Marescau Eds., Plenum Press, liew York (1983) pp 449–458.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Plenum Press, New York
About this chapter
Cite this chapter
Nagase, S. et al. (1989). Is Guanidine a Marker of Peroxidation in Uremics?. In: Mori, A., Cohen, B.D., Koide, H. (eds) Guanidines 2. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0821-8_33
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0821-8_33
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8099-6
Online ISBN: 978-1-4613-0821-8
eBook Packages: Springer Book Archive